Aleksandra Petrovic Fabijan; Nouri L. Ben Zakour; Josephine Ho; Ruby C.Y. Lin; Jonathan Iredell, PhD; for the Westmead Bacteriophage Therapy Team (WBTT) and AmpliPhi Biosciences Corporation *
Acknowledgment: The authors thank Joey Lai and Li Ma at Westmead Institute for Medical Research and the staff of the Pathogen Genomics Unit at Westmead Hospital and Ramaciotti Centre (University of New South Wales) for technical advice and sequencing support; Angela Netluch and Patricia Fa for pharmacy support; Stephanie Chan, Katherine Garnham, Sonya Natasha Hutabarat, Cecilia Li, Chris Robson, Andrew Ginn, and the staff of the New South Wales Pathology Microbiology laboratory at Westmead Hospital for help with data and sample collection; and Bethany Bowring for laboratory assistance.
Financial Support: ABPH provided the investigational product AB-SA01 and partial financial support for work carried out at Western Sydney Local Health District and Westmead Institute for Medical Research to treat patients and analysis of samples, as investigator-led research sponsored and indemnified by Western Sydney Local Health District. Dr. Iredell is supported by grants 1104232 and 1107322 from the Australian National Health and Medical Research Council.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L19-0369.
Fabijan AP, Ben Zakour NL, Ho J, et al, for the Westmead Bacteriophage Therapy Team (WBTT) and AmpliPhi Biosciences Corporation. Polyclonal Staphylococcus aureus Bacteremia. Ann Intern Med. 2019;:. [Epub ahead of print 17 September 2019]. doi: https://doi.org/10.7326/L19-0369
Download citation file:
© 2019
Published: Ann Intern Med. 2019.
DOI: 10.7326/L19-0369
Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by: